Innovent Announces the China NMPA Approval of TYVYT® (sintilimab injection) in Combination with BYVASDA® (bevacizumab biosimilar injection) as First-Line Therapy for People with Hepatocellular Carcinoma

SAN FRANCISCO and SUZHOU, China, June 28, 2021 /PRNewswire/ — Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a…

Xiamen Tourism Expo 2021 comes to successful conclusion

XIAMEN, China, June 28, 2021 /PRNewswire/ — The 17th Straits Tourism Expo and the 7th China…

Nium and Pelikin Partnership Enables Seamless Digital Financial Services to Millions of Global Travellers

MELBOURNE, Australia, June 28, 2021 /PRNewswire/ — With the travel industry poised for a big recovery…